DA
Danieli Andrade
Also known as: Danieli Castro Oliveira de Andrade
Universidade de São Paulo
Research areas: Medicine · Rheumatology · Systemic Lupus Erythematosus Research · Vasculitis and related conditions · Systemic Sclerosis and Related Diseases
0000-0002-0381-1808
Employment
- 2011 - Present
Education
-
University of Sao Paulo Associate Professor
-
University of Sao Paulo Associate Professor
Projects & Funding
Projects & funding information is unavailable.
Publications (65)
- Articular involvement in antiphospholipid syndrome: Clinical, laboratory, and imaging characterization Save
- Cognition and Disability in AQP4-IgG NMOSD Save
- Clinical characteristics of patients with primary antiphospholipid syndrome and “single” antiphospholipid antibody: Retrospective results from the APS ACTION clinical database and repository (“registry”) Save
- Differences in the clinical profile between isolated lupus anticoagulant and triplepositive antiphospholipid antibody profiles in primary antiphospholipid syndrome Save
- Evaluation of anticoagulation quality in patients with primary antiphospholipid syndrome at a tertiary hospital Save
- Terapias inovadoras – terapia CAR-T: o que os reumatologistas estão aprendendo com a experiência da onco-hematologia? Save
- IgM antiphospholipid antibodies are associated with a microvascular phenotype in antiphospholipid syndrome Save
- Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority study Save
- Rheumatic Immune-Related Adverse Events in Patients with Metastatic Melanoma: Insights for Treatment from a Single Cancer Center Save
- ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (“Registry”) Save
- Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository… Save
- Damage Index for Antiphospholipid Syndrome (DIAPS): An Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) “Damage” working group report on strengths and limitations Save
- Early subclinical macular disease in asymptomatic patients with primary antiphospholipid syndrome: A quantitative multimodal retinal evaluation Save
- Cardiorespiratory abnormalities in ICU survivors of COVID-19 with postacute sequelae of SARS-CoV-2 infection are unrelated to invasive mechanical ventilation Save
- Cerebrovascular disease in patients with antiphospholipid antibody syndrome: a transcranial Doppler and magnetic resonance imaging study Save
- 2023 ACR/EULAR antiphospholipid syndrome classification criteria Save
- Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”) Save
- Ocular findings in asymptomatic patients with primary antiphospholipid syndrome Save
- Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (‘Registry’) Save
- CoaguChek® XS versus standard laboratory prothrombin time for anticoagulant monitoring in patients with antiphospholipid syndrome Save